ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 100 filers reported holding ATHIRA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,499,533 | -36.8% | 742,343 | -7.7% | 0.00% | 0.0% |
| Q2 2023 | $2,373,051 | +178324.9% | 804,424 | +51.2% | 0.00% | 0.0% |
| Q1 2023 | $1,330 | +1056.5% | 531,941 | +1360.3% | 0.00% | – |
| Q4 2022 | $115 | -99.9% | 36,426 | +27.8% | 0.00% | – |
| Q3 2022 | $85,000 | -19.0% | 28,512 | -16.9% | 0.00% | – |
| Q2 2022 | $105,000 | -80.2% | 34,308 | -33.8% | 0.00% | – |
| Q2 2021 | $531,000 | -94.3% | 51,843 | -89.8% | 0.00% | -100.0% |
| Q1 2021 | $9,391,000 | +166.6% | 510,395 | +396.3% | 0.01% | +133.3% |
| Q4 2020 | $3,522,000 | -15.4% | 102,846 | -54.4% | 0.00% | -40.0% |
| Q3 2020 | $4,163,000 | – | 225,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |